Toll Free: 1-888-928-9744

Infection Surveillance Solutions Market Analysis Report By End Use (Hospitals, Care Centers), By Product and Services, By Infection (Surgical Site, Urinary Tract, Blood Stream), And Segment Forecasts, 2018 - 2026

Published: Dec, 2018 | Pages: 91 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global infection surveillance solutions market size is poised to reach USD 1.0 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 14.3% during the forecast period. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in European Union (EU) from antibiotic resistant bacteria. The figure is expected to increase to 10 million deaths per year, if current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up AMR surveillance network in India.

Further key findings from the report suggest:

• Surgical site infections emerged as the most promising segment during the forecast period owing to increasing number of surgeries being performed worldwide

• On the basis of the product and services segment, the on-premise software segment commanded the largest share in the market owing to its increased usage

• North America dominated the market in 2017. Government programs and rising awareness about infection surveillance are facilitating the dominance of this region during the forecast period

• Asia Pacific is estimated to witness swift growth during the forecast period due to increasing establishment of hospital chains and huge patient population

• Few of the key market players are Wolters Kluwer N.V; Gojo Industries; Becton; Dickinson and Company; RL Solutions; Baxter International Inc.; Premier Inc.; and Truven Health Analytics (An IBM Company).
 Table of Contents

Chapter 1 Research Methodology
                 1.1 Information Procurement
                 1.2 Data Analysis
                 1.3 Approaches For Market Estimation
                     1.3.1 Approach 1: Demand analysis & bottom up approach
                     1.3.2 Approach 2: Top down market estimation
                     1.3.3 Approach 3: Commodity flow and bottom up market estimation
                     1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
                 2.1 Market Snapshot
                 2.2 Primary Data Analysis
Chapter 3 Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                 3.2 Market Driver Analysis
                     3.2.1 Increasing occurences of hospital acquired infections
                     3.2.2 Changing healthcare scenario and rising automation
                     3.2.3 Advancements in the IT infrastructure
                     3.2.4 Increasing number of helathcare settings worldwide
                 3.3 Market Restraint Analysis
                     3.3.1 Data security risks
                     3.3.2 Inadequate data management and limited computing resources
                 3.4 Penetration & Growth Prospect Mapping
                 3.5 Infection Surveillance Solutions Market - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                 3.6 Industry Analysis - Porter's
                     3.6.1 Threat of new entrants
                     3.6.2 Competitive rivalry
                     3.6.3 Bargaining power of suppliers
                     3.6.4 Bargaining power of buyers
                     3.6.5 Threat of substitutes
Chapter 4 Infection Surveillance Solutions Market: Product and Services Estimates & Trend Analysis
                 4.1 Infection Surveillance Solutions Market: Product and Services Movement Analysis
                 4.2 Software 
                     4.2.1 Software market estimates and forecasts, 2014 - 2026 (USD Million)
                         4.2.1.1 On-premise
                             4.2.1.1.1 On-premise market estimates and forecasts, 2014 - 2026 (USD Million)
                         4.2.1.2 Web-based 
                             4.2.1.2.1 Web-based market estimates and forecasts, 2014 - 2026 (USD Million)
                 4.3 Services
                     4.3.1 Services market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 5 Infection Surveillance Solutions Market: By Infection Type Estimates & Trend Analysis
                 5.1 Infection Surveillance Solutions Market: Infection Type Movement Analysis
                 5.2 Surgical Site Infections (SSI)
                     5.2.1 Surgical site infections market estimates and forecasts, 2014 - 2026 (USD Million)
                 5.3 Blood-stream Infections (BSI)
                     5.3.1. Blood stream infections market estimates and forecasts, 2014 - 2026 (USD Million)
                 5.4 Urinary Tract Infections (UTI)
                     5.4.1 Urinary tract infections market estimates and forecasts, 2014 - 2026 (USD Million)
                 5.5 Others ( Pneumonia and antibiotic resistant bacteria)
                     5.5.1 Others market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 6 Infection Surveillance Solutions Market: By End-use Estimates & Trend Analysis
                 6.1 Infection Surveillance Solutions Market: End-use Movement Analysis
                 6.2 Long Term Care Facilities
                     6.2.1 Long Term Care Facilities market estimates and forecasts, 2014 - 2026 (USD Million)
                 6.3 Hospitals
                     6.3.1 Hospitals market estimates and forecasts, 2014 - 2026 (USD Million)
                 6.4 Others (Clinics and Ambulatory Surgical Centers)
                     6.4.1 Others market estimates and forecasts, 2014 - 2026 (USD Million)
Chapter 7 Infection Surveillance Solutions Market: Regional Estimates & Trend Analysis
                 7.1 Infection Surveillance Solutions Market: Regional Movement Analysis
                 7.2 North America
                     7.2.1 North America market estimates and forecasts, 2014 - 2026 (USD Million)
                     7.2.2 U.S.
                         7.2.2.1 U.S.market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.2.2.2 U.S.market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.2.2.3 U.S.market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                     7.2.3 Canada
                         7.2.3.1 Canada market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.2.3.2 Canada market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.2.3.3 Canada market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                 7.3 Europe
                     7.3.1 Europe market estimates and forecasts, 2014 - 2026 (USD Million)
                     7.3.2 U.K.
                         7.3.2.1 U.K. market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.3.2.2 U.K. market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.3.2.3 U.K. market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                     7.3.3 Germany
                         7.3.3.1 Germany market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.3.3.2 Germany market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.3.3.3 Germany market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                 7.4 Asia Pacific
                     7.4.1 Asia Pacific market estimates and forecasts, 2014 - 2026 (USD Million)
                     7.4.2 China
                         7.4.2.1 China market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.4.2.2 China market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.4.2.3 China market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                     7.4.3 Japan
                         7.4.3.1 Japan market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.4.3.2 Japan market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.4.3.3 Japan market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                 7.5 Latin America
                     7.5.1 Latin America market estimates and forecasts, 2014 - 2026 (USD Million)
                     7.5.2 Brazil
                         7.5.2.1 Brazil market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.5.2.2 Brazil market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.5.2.3 Brazil market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                     7.5.3 Mexico
                         7.5.3.1 Mexico market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.5.3.2 Mexico market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.5.3.3 Mexico market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                 7.6 Middle East and Africa (MEA)
                     7.6.1 MEA market estimates and forecasts, 2014 - 2026 (USD Million)
                     7.6.2 Saudi Arabia
                         7.6.2.1 Saudi Arabia market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.6.2.2 Saudi Arabia market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.6.2.3 Saudi Arabia market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
                     7.6.3 South Africa
                         7.6.3.1 South Africa market estimates & forecasts, by product and services, 2014 - 2026 (USD Million)
                         7.6.3.2 South Africa market estimates & forecasts, by infection type, 2014 - 2026 (USD Million)
                         7.6.3.3 South Africa market estimates & forecasts, by end-use, 2014 - 2026 (USD Million)
Chapter 8 Competitive Landscape
                 8.1 Strategic Framework
                 8.2 Company Profiles
                     8.2.1 Becton, Dickinson and Company
                         8.2.1.1 Company overview
                         8.2.1.2 Financial performance
                         8.2.1.3 Product benchmarking
                         8.2.1.4 Strategic initiatives
                     8.2.2 Premier Inc.
                         8.2.2.1 Company overview
                         8.2.2.2 Financial performance
                         8.2.2.3 Product benchmarking
                         8.2.2.4 Strategic initiatives
                     8.2.3 Wolters Kluwer N.V
                         8.2.3.1 Company overview
                         8.2.3.2 Financial performance
                         8.2.3.3 Product benchmarking
                         8.2.3.4 Strategic initiatives
                     8.2.4 Baxter International Inc.
                         8.2.4.1 Company overview
                         8.2.4.2 Financial performance
                         8.2.4.3 Product benchmarking
                         8.2.4.4 Strategic initiatives
                     8.2.5 Atlas Medical Software
                         8.2.5.1 Company overview
                         8.2.5.2 Product benchmarking
                         8.2.5.3 Strategic initiatives
                     8.2.6 GOJO Industries, Inc.
                         8.2.6.1 Company overview
                         8.2.6.2 Product benchmarking
                         8.2.6.3 Strategic initiatives
                     8.2.7 Truven Health Analytics (acquired by IBM Corporation)
                         8.2.7.1 Company overview
                         8.2.7.2 Product benchmarking
                         8.2.7.3 Strategic initiatives
                     8.2.8 RL Solutions Inc.
                         8.2.8.1 Company overview
                         8.2.8.2 Product benchmarking
                         8.2.8.3 Strategic initiatives
                     8.2.9 Deb Group Limited
                         8.2.9.1 Company overview
                         8.2.9.2 Product benchmarking
                         8.2.9.3 Strategic initiatives
                     8.2.10 HyGreen Inc.
                         8.2.10.1 Company overview
                         8.2.10.2 Product benchmarking
                         8.2.10.3 Strategic initiatives
List of Tables

Table 1 Global Infection Surveillance Solutions Market Estimates & Forecasts, by Region, 2014 - 2026 (USD Million)
Table 2 Global Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 3 Global Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 4 Global Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 5 Global Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 6 North America Infection Surveillance Solutions Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 7 North America Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 8 North America Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 9 North America Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 10 North America Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 11 U.S. Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 12 U.S. Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 13 U.S. Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 14 U.S. Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 15 Canada Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 16 Canada Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 17 Canada Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 18 Canada Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 19 Europe Infection Surveillance Solutions Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 20 Europe Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 21 Europe Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 22 Europe Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 23 Europe Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 24 U.K. Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 25 U.K. Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 26 U.K. Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 27 U.K. Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 28 Germany Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 29 Germany Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 30 Germany Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 31 Germany Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 32 Asia Pacific Infection Surveillance Solutions Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 33 Asia Pacific Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 34 Asia Pacific Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 35 Asia Pacific Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 36 Asia Pacific Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 37 Japan Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 38 Japan Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 39 Japan Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 40 Japan Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 41 China Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 42 China Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 43 China Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 44 China Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 45 Latin America Infection Surveillance Solutions Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 46 Latin America Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 47 Latin America Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 48 Latin America Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 49 Latin America Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 50 Brazil Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 51 Brazil Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 52 Brazil Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 53 Brazil Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 54 Mexico Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 55 Mexico Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 56 Mexico Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 57 Mexico Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 58 MEA Infection Surveillance Solutions Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 59 MEA Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 60 MEA Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 61 MEA Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 62 MEA Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 63 Saudi Arabia Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 64 Saudi Arabia Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 65 Saudi Arabia Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 66 Saudi Arabia Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million)
Table 67 South Africa Infection Surveillance Solutions Market Estimates & Forecasts, by Product and Services, 2014 - 2026 (USD Million)
Table 68 South Africa Infection Surveillance Solutions Market Estimates & Forecasts, by Software, 2014 - 2026 (USD Million)
Table 69 South Africa Infection Surveillance Solutions Market Estimates & Forecasts, by Infection Type, 2014 - 2026 (USD Million)
Table 70 South Africa Infection Surveillance Solutions Market Estimates & Forecasts, by End-use, 2014 - 2026 (USD Million) 


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary (USD Million)
Fig. 8 Primary Data Analysis : Infection Surveillance Solutions Market
Fig. 9 Market trends & outlook
Fig. 10 Market segmentation & scope
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 15 Porter's Five Forces Analysis
Fig. 16 Infection Surveillance Solutions Market: Product and Services outlook key takeaways
Fig. 17 Infection Surveillance Solutions Market: Product and Services movement analysis
Fig. 18 Software market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 19 On-premise Software market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 20 Web-based Software market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 21 Services market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 22 Infection Surveillance Solutions Market: Infection type outlook key takeaways 
Fig. 23 Infection Surveillance Solutions Market: Infection type movement analysis
Fig. 24 Surgical Site Infections market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 25 Blood Stream Infections market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 26 Urinary Tract Infections market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 27 Others Infections market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 28 Infection Surveillance Solutions Market: End-use outlook key takeaways 
Fig. 29 Infection Surveillance Solutions Market: End-use movement analysis
Fig. 30 Long Term Care Centers market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 31 Hospitals market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 32 Others market estimates & forecasts, 2014 - 2026 (USD Million)
Fig. 33 Regional market place, key takeaways
Fig. 34 Regional outlook, 2014 & 2026
Fig. 35 North America Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 36 U.S. Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 37 Canada Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 38 Europe Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 39 U.K. Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 40 Germany Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 41 Asia Pacific Infection Surveillance Solutions Market, 2014 - 2026 (USD Million
Fig. 42 Japan Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 43 China Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 44 Latin America Infection Surveillance Solutions Market, 2014 - 2026 (USD Million
Fig. 45 Brazil Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 46 Mexico Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 47 MEA Infection Surveillance Solutions Market, 2014 - 2026 (USD Million
Fig. 48 Saudi Arab Infection Surveillance Solutions Market, 2014 - 2026 (USD Million)
Fig. 49 South Africa Infection Surveillance Solutions Market, 2014 - 2026 (USD Million
Fig. 50 Strategy Framework
Fig. 51 Market Participant Categorization

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $4950
Multi User - US $5950
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify